nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Paraesthesia—Rosuvastatin—coronary artery disease	0.00305	0.00309	CcSEcCtD
Mecamylamine—Syncope—Eplerenone—coronary artery disease	0.00303	0.00307	CcSEcCtD
Mecamylamine—Dizziness—Penbutolol—coronary artery disease	0.00299	0.00303	CcSEcCtD
Mecamylamine—Loss of consciousness—Eplerenone—coronary artery disease	0.00297	0.00301	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Lisinopril—coronary artery disease	0.00297	0.00301	CcSEcCtD
Mecamylamine—Vision blurred—Valsartan—coronary artery disease	0.00293	0.00297	CcSEcCtD
Mecamylamine—Vision blurred—Olmesartan—coronary artery disease	0.00292	0.00296	CcSEcCtD
Mecamylamine—Constipation—Rosuvastatin—coronary artery disease	0.0029	0.00294	CcSEcCtD
Mecamylamine—Erectile dysfunction—Ramipril—coronary artery disease	0.00285	0.00289	CcSEcCtD
Mecamylamine—Vision blurred—Niacin—coronary artery disease	0.00285	0.00289	CcSEcCtD
Mecamylamine—Shock—Clopidogrel—coronary artery disease	0.00285	0.00289	CcSEcCtD
Mecamylamine—Vision blurred—Pravastatin—coronary artery disease	0.00281	0.00285	CcSEcCtD
Mecamylamine—Anorexia—Fenofibrate—coronary artery disease	0.00281	0.00284	CcSEcCtD
Mecamylamine—Tremor—Pravastatin—coronary artery disease	0.00279	0.00283	CcSEcCtD
Mecamylamine—Syncope—Valsartan—coronary artery disease	0.00279	0.00283	CcSEcCtD
Mecamylamine—Erectile dysfunction—Timolol—coronary artery disease	0.00279	0.00283	CcSEcCtD
Mecamylamine—Syncope—Olmesartan—coronary artery disease	0.00278	0.00281	CcSEcCtD
Mecamylamine—Asthenia—Gemfibrozil—coronary artery disease	0.00277	0.00281	CcSEcCtD
Mecamylamine—Anorexia—Lovastatin—coronary artery disease	0.00274	0.00278	CcSEcCtD
Mecamylamine—Loss of consciousness—Valsartan—coronary artery disease	0.00273	0.00277	CcSEcCtD
Mecamylamine—Loss of consciousness—Olmesartan—coronary artery disease	0.00272	0.00276	CcSEcCtD
Mecamylamine—Shock—Eplerenone—coronary artery disease	0.00271	0.00275	CcSEcCtD
Mecamylamine—Vision blurred—Enalapril—coronary artery disease	0.00271	0.00275	CcSEcCtD
Mecamylamine—Syncope—Niacin—coronary artery disease	0.00271	0.00275	CcSEcCtD
Mecamylamine—Asthenia—Ticagrelor—coronary artery disease	0.0027	0.00274	CcSEcCtD
Mecamylamine—Tremor—Enalapril—coronary artery disease	0.0027	0.00274	CcSEcCtD
Mecamylamine—Nausea—Penbutolol—coronary artery disease	0.00269	0.00272	CcSEcCtD
Mecamylamine—Loss of consciousness—Niacin—coronary artery disease	0.00266	0.0027	CcSEcCtD
Mecamylamine—Paraesthesia—Fenofibrate—coronary artery disease	0.00264	0.00268	CcSEcCtD
Mecamylamine—Vision blurred—Captopril—coronary artery disease	0.0026	0.00264	CcSEcCtD
Mecamylamine—Paraesthesia—Clopidogrel—coronary artery disease	0.0026	0.00263	CcSEcCtD
Mecamylamine—Syncope—Trandolapril—coronary artery disease	0.00259	0.00263	CcSEcCtD
Mecamylamine—Erectile dysfunction—Lisinopril—coronary artery disease	0.00259	0.00262	CcSEcCtD
Mecamylamine—Syncope—Enalapril—coronary artery disease	0.00258	0.00262	CcSEcCtD
Mecamylamine—Paraesthesia—Lovastatin—coronary artery disease	0.00258	0.00262	CcSEcCtD
Mecamylamine—Anorexia—Simvastatin—coronary artery disease	0.00256	0.0026	CcSEcCtD
Mecamylamine—Decreased appetite—Fenofibrate—coronary artery disease	0.00256	0.00259	CcSEcCtD
Mecamylamine—Dizziness—Gemfibrozil—coronary artery disease	0.00255	0.00259	CcSEcCtD
Mecamylamine—Syncope—Telmisartan—coronary artery disease	0.00255	0.00258	CcSEcCtD
Mecamylamine—Loss of consciousness—Trandolapril—coronary artery disease	0.00254	0.00258	CcSEcCtD
Mecamylamine—Fatigue—Fenofibrate—coronary artery disease	0.00254	0.00257	CcSEcCtD
Mecamylamine—Loss of consciousness—Enalapril—coronary artery disease	0.00253	0.00257	CcSEcCtD
Mecamylamine—Paraesthesia—Ezetimibe—coronary artery disease	0.00253	0.00257	CcSEcCtD
Mecamylamine—Constipation—Fenofibrate—coronary artery disease	0.00252	0.00255	CcSEcCtD
Mecamylamine—Tremor—Perindopril—coronary artery disease	0.00251	0.00255	CcSEcCtD
Mecamylamine—Decreased appetite—Lovastatin—coronary artery disease	0.0025	0.00253	CcSEcCtD
Mecamylamine—Shock—Valsartan—coronary artery disease	0.0025	0.00253	CcSEcCtD
Mecamylamine—Loss of consciousness—Telmisartan—coronary artery disease	0.0025	0.00253	CcSEcCtD
Mecamylamine—Fatigue—Clopidogrel—coronary artery disease	0.00249	0.00253	CcSEcCtD
Mecamylamine—Dizziness—Ticagrelor—coronary artery disease	0.00249	0.00253	CcSEcCtD
Mecamylamine—Shock—Olmesartan—coronary artery disease	0.00249	0.00252	CcSEcCtD
Mecamylamine—Fatigue—Lovastatin—coronary artery disease	0.00248	0.00251	CcSEcCtD
Mecamylamine—Syncope—Captopril—coronary artery disease	0.00248	0.00251	CcSEcCtD
Mecamylamine—Constipation—Clopidogrel—coronary artery disease	0.00247	0.00251	CcSEcCtD
Mecamylamine—Constipation—Lovastatin—coronary artery disease	0.00246	0.00249	CcSEcCtD
Mecamylamine—Vision blurred—Furosemide—coronary artery disease	0.00246	0.00249	CcSEcCtD
Mecamylamine—Vomiting—Gemfibrozil—coronary artery disease	0.00245	0.00249	CcSEcCtD
Mecamylamine—Decreased appetite—Ezetimibe—coronary artery disease	0.00245	0.00248	CcSEcCtD
Mecamylamine—Asthenia—Rosuvastatin—coronary artery disease	0.00243	0.00247	CcSEcCtD
Mecamylamine—Fatigue—Ezetimibe—coronary artery disease	0.00243	0.00246	CcSEcCtD
Mecamylamine—Shock—Niacin—coronary artery disease	0.00243	0.00246	CcSEcCtD
Mecamylamine—Loss of consciousness—Captopril—coronary artery disease	0.00243	0.00246	CcSEcCtD
Mecamylamine—Anorexia—Valsartan—coronary artery disease	0.00242	0.00245	CcSEcCtD
Mecamylamine—Paraesthesia—Simvastatin—coronary artery disease	0.00241	0.00245	CcSEcCtD
Mecamylamine—Constipation—Ezetimibe—coronary artery disease	0.00241	0.00244	CcSEcCtD
Mecamylamine—Anorexia—Olmesartan—coronary artery disease	0.00241	0.00244	CcSEcCtD
Mecamylamine—Syncope—Perindopril—coronary artery disease	0.00241	0.00244	CcSEcCtD
Mecamylamine—Vomiting—Ticagrelor—coronary artery disease	0.0024	0.00243	CcSEcCtD
Mecamylamine—Fatigue—Eplerenone—coronary artery disease	0.00238	0.00241	CcSEcCtD
Mecamylamine—Vision blurred—Losartan—coronary artery disease	0.00237	0.0024	CcSEcCtD
Mecamylamine—Constipation—Eplerenone—coronary artery disease	0.00236	0.00239	CcSEcCtD
Mecamylamine—Loss of consciousness—Perindopril—coronary artery disease	0.00236	0.00239	CcSEcCtD
Mecamylamine—Tremor—Losartan—coronary artery disease	0.00236	0.00239	CcSEcCtD
Mecamylamine—Anorexia—Niacin—coronary artery disease	0.00235	0.00239	CcSEcCtD
Mecamylamine—Decreased appetite—Simvastatin—coronary artery disease	0.00234	0.00237	CcSEcCtD
Mecamylamine—Shock—Trandolapril—coronary artery disease	0.00232	0.00235	CcSEcCtD
Mecamylamine—Fatigue—Simvastatin—coronary artery disease	0.00232	0.00235	CcSEcCtD
Mecamylamine—Anorexia—Pravastatin—coronary artery disease	0.00232	0.00235	CcSEcCtD
Mecamylamine—Shock—Enalapril—coronary artery disease	0.00231	0.00234	CcSEcCtD
Mecamylamine—Constipation—Simvastatin—coronary artery disease	0.0023	0.00233	CcSEcCtD
Mecamylamine—Nausea—Gemfibrozil—coronary artery disease	0.00229	0.00232	CcSEcCtD
Mecamylamine—Shock—Telmisartan—coronary artery disease	0.00228	0.00231	CcSEcCtD
Mecamylamine—Paraesthesia—Valsartan—coronary artery disease	0.00228	0.00231	CcSEcCtD
Mecamylamine—Syncope—Losartan—coronary artery disease	0.00226	0.00229	CcSEcCtD
Mecamylamine—Anorexia—Trandolapril—coronary artery disease	0.00225	0.00228	CcSEcCtD
Mecamylamine—Dizziness—Rosuvastatin—coronary artery disease	0.00224	0.00227	CcSEcCtD
Mecamylamine—Anorexia—Enalapril—coronary artery disease	0.00224	0.00227	CcSEcCtD
Mecamylamine—Nausea—Ticagrelor—coronary artery disease	0.00224	0.00227	CcSEcCtD
Mecamylamine—Shock—Captopril—coronary artery disease	0.00222	0.00225	CcSEcCtD
Mecamylamine—Paraesthesia—Niacin—coronary artery disease	0.00222	0.00225	CcSEcCtD
Mecamylamine—Loss of consciousness—Losartan—coronary artery disease	0.00221	0.00224	CcSEcCtD
Mecamylamine—Anorexia—Telmisartan—coronary artery disease	0.00221	0.00224	CcSEcCtD
Mecamylamine—Decreased appetite—Valsartan—coronary artery disease	0.00221	0.00224	CcSEcCtD
Mecamylamine—Decreased appetite—Olmesartan—coronary artery disease	0.0022	0.00223	CcSEcCtD
Mecamylamine—Fatigue—Valsartan—coronary artery disease	0.00219	0.00222	CcSEcCtD
Mecamylamine—Paraesthesia—Pravastatin—coronary artery disease	0.00218	0.00221	CcSEcCtD
Mecamylamine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00218	0.00221	CcSEcCtD
Mecamylamine—Fatigue—Olmesartan—coronary artery disease	0.00218	0.00221	CcSEcCtD
Mecamylamine—Constipation—Valsartan—coronary artery disease	0.00217	0.0022	CcSEcCtD
Mecamylamine—Constipation—Olmesartan—coronary artery disease	0.00216	0.00219	CcSEcCtD
Mecamylamine—Shock—Perindopril—coronary artery disease	0.00215	0.00218	CcSEcCtD
Mecamylamine—Anorexia—Captopril—coronary artery disease	0.00215	0.00218	CcSEcCtD
Mecamylamine—Decreased appetite—Niacin—coronary artery disease	0.00215	0.00218	CcSEcCtD
Mecamylamine—Paraesthesia—Trandolapril—coronary artery disease	0.00212	0.00215	CcSEcCtD
Mecamylamine—Decreased appetite—Pravastatin—coronary artery disease	0.00211	0.00214	CcSEcCtD
Mecamylamine—Asthenia—Fenofibrate—coronary artery disease	0.00211	0.00214	CcSEcCtD
Mecamylamine—Paraesthesia—Enalapril—coronary artery disease	0.00211	0.00214	CcSEcCtD
Mecamylamine—Fatigue—Pravastatin—coronary artery disease	0.0021	0.00212	CcSEcCtD
Mecamylamine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00209	0.00212	CcSEcCtD
Mecamylamine—Shock—Furosemide—coronary artery disease	0.00209	0.00212	CcSEcCtD
Mecamylamine—Anorexia—Perindopril—coronary artery disease	0.00209	0.00212	CcSEcCtD
Mecamylamine—Paraesthesia—Telmisartan—coronary artery disease	0.00208	0.00211	CcSEcCtD
Mecamylamine—Constipation—Pravastatin—coronary artery disease	0.00208	0.00211	CcSEcCtD
Mecamylamine—Asthenia—Clopidogrel—coronary artery disease	0.00208	0.0021	CcSEcCtD
Mecamylamine—Asthenia—Lovastatin—coronary artery disease	0.00206	0.00209	CcSEcCtD
Mecamylamine—Decreased appetite—Trandolapril—coronary artery disease	0.00205	0.00208	CcSEcCtD
Mecamylamine—Decreased appetite—Enalapril—coronary artery disease	0.00204	0.00207	CcSEcCtD
Mecamylamine—Fatigue—Trandolapril—coronary artery disease	0.00203	0.00206	CcSEcCtD
Mecamylamine—Anorexia—Furosemide—coronary artery disease	0.00203	0.00206	CcSEcCtD
Mecamylamine—Fatigue—Enalapril—coronary artery disease	0.00203	0.00205	CcSEcCtD
Mecamylamine—Paraesthesia—Captopril—coronary artery disease	0.00202	0.00205	CcSEcCtD
Mecamylamine—Asthenia—Ezetimibe—coronary artery disease	0.00202	0.00205	CcSEcCtD
Mecamylamine—Tremor—Ramipril—coronary artery disease	0.00202	0.00205	CcSEcCtD
Mecamylamine—Shock—Losartan—coronary artery disease	0.00202	0.00205	CcSEcCtD
Mecamylamine—Constipation—Trandolapril—coronary artery disease	0.00202	0.00205	CcSEcCtD
Mecamylamine—Decreased appetite—Telmisartan—coronary artery disease	0.00202	0.00204	CcSEcCtD
Mecamylamine—Nausea—Rosuvastatin—coronary artery disease	0.00201	0.00204	CcSEcCtD
Mecamylamine—Constipation—Enalapril—coronary artery disease	0.00201	0.00204	CcSEcCtD
Mecamylamine—Fatigue—Telmisartan—coronary artery disease	0.002	0.00203	CcSEcCtD
Mecamylamine—Vision blurred—Timolol—coronary artery disease	0.00199	0.00202	CcSEcCtD
Mecamylamine—Constipation—Telmisartan—coronary artery disease	0.00198	0.00201	CcSEcCtD
Mecamylamine—Asthenia—Eplerenone—coronary artery disease	0.00198	0.00201	CcSEcCtD
Mecamylamine—Paraesthesia—Perindopril—coronary artery disease	0.00197	0.00199	CcSEcCtD
Mecamylamine—Decreased appetite—Captopril—coronary artery disease	0.00196	0.00199	CcSEcCtD
Mecamylamine—Anorexia—Losartan—coronary artery disease	0.00196	0.00198	CcSEcCtD
Mecamylamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.00196	0.00198	CcSEcCtD
Mecamylamine—Dizziness—Fenofibrate—coronary artery disease	0.00195	0.00197	CcSEcCtD
Mecamylamine—Fatigue—Captopril—coronary artery disease	0.00194	0.00197	CcSEcCtD
Mecamylamine—Syncope—Ramipril—coronary artery disease	0.00193	0.00196	CcSEcCtD
Mecamylamine—Asthenia—Simvastatin—coronary artery disease	0.00193	0.00196	CcSEcCtD
Mecamylamine—Constipation—Captopril—coronary artery disease	0.00193	0.00195	CcSEcCtD
Mecamylamine—Dizziness—Clopidogrel—coronary artery disease	0.00191	0.00194	CcSEcCtD
Mecamylamine—Paraesthesia—Furosemide—coronary artery disease	0.00191	0.00194	CcSEcCtD
Mecamylamine—Decreased appetite—Perindopril—coronary artery disease	0.0019	0.00193	CcSEcCtD
Mecamylamine—Dizziness—Lovastatin—coronary artery disease	0.0019	0.00193	CcSEcCtD
Mecamylamine—Loss of consciousness—Ramipril—coronary artery disease	0.0019	0.00192	CcSEcCtD
Mecamylamine—Syncope—Timolol—coronary artery disease	0.00189	0.00192	CcSEcCtD
Mecamylamine—Fatigue—Perindopril—coronary artery disease	0.00189	0.00191	CcSEcCtD
Mecamylamine—Constipation—Perindopril—coronary artery disease	0.00187	0.0019	CcSEcCtD
Mecamylamine—Vomiting—Fenofibrate—coronary artery disease	0.00187	0.0019	CcSEcCtD
Mecamylamine—Convulsion—Ramipril—coronary artery disease	0.00187	0.0019	CcSEcCtD
Mecamylamine—Dizziness—Ezetimibe—coronary artery disease	0.00186	0.00189	CcSEcCtD
Mecamylamine—Loss of consciousness—Timolol—coronary artery disease	0.00185	0.00188	CcSEcCtD
Mecamylamine—Decreased appetite—Furosemide—coronary artery disease	0.00185	0.00188	CcSEcCtD
Mecamylamine—Vision blurred—Lisinopril—coronary artery disease	0.00184	0.00187	CcSEcCtD
Mecamylamine—Paraesthesia—Losartan—coronary artery disease	0.00184	0.00187	CcSEcCtD
Mecamylamine—Vomiting—Clopidogrel—coronary artery disease	0.00184	0.00187	CcSEcCtD
Mecamylamine—Fatigue—Furosemide—coronary artery disease	0.00183	0.00186	CcSEcCtD
Mecamylamine—Tremor—Lisinopril—coronary artery disease	0.00183	0.00186	CcSEcCtD
Mecamylamine—Vomiting—Lovastatin—coronary artery disease	0.00183	0.00185	CcSEcCtD
Mecamylamine—Dizziness—Eplerenone—coronary artery disease	0.00182	0.00185	CcSEcCtD
Mecamylamine—Asthenia—Valsartan—coronary artery disease	0.00182	0.00185	CcSEcCtD
Mecamylamine—Constipation—Furosemide—coronary artery disease	0.00182	0.00185	CcSEcCtD
Mecamylamine—Asthenia—Olmesartan—coronary artery disease	0.00181	0.00184	CcSEcCtD
Mecamylamine—Vomiting—Ezetimibe—coronary artery disease	0.00179	0.00182	CcSEcCtD
Mecamylamine—Decreased appetite—Losartan—coronary artery disease	0.00178	0.00181	CcSEcCtD
Mecamylamine—Dizziness—Simvastatin—coronary artery disease	0.00178	0.0018	CcSEcCtD
Mecamylamine—Asthenia—Niacin—coronary artery disease	0.00177	0.0018	CcSEcCtD
Mecamylamine—Fatigue—Losartan—coronary artery disease	0.00177	0.00179	CcSEcCtD
Mecamylamine—Constipation—Losartan—coronary artery disease	0.00176	0.00178	CcSEcCtD
Mecamylamine—Syncope—Lisinopril—coronary artery disease	0.00175	0.00178	CcSEcCtD
Mecamylamine—Vomiting—Eplerenone—coronary artery disease	0.00175	0.00178	CcSEcCtD
Mecamylamine—Nausea—Fenofibrate—coronary artery disease	0.00175	0.00177	CcSEcCtD
Mecamylamine—Asthenia—Pravastatin—coronary artery disease	0.00174	0.00177	CcSEcCtD
Mecamylamine—Shock—Ramipril—coronary artery disease	0.00173	0.00176	CcSEcCtD
Mecamylamine—Loss of consciousness—Lisinopril—coronary artery disease	0.00172	0.00174	CcSEcCtD
Mecamylamine—Nausea—Clopidogrel—coronary artery disease	0.00172	0.00174	CcSEcCtD
Mecamylamine—Vomiting—Simvastatin—coronary artery disease	0.00171	0.00173	CcSEcCtD
Mecamylamine—Nausea—Lovastatin—coronary artery disease	0.00171	0.00173	CcSEcCtD
Mecamylamine—Asthenia—Trandolapril—coronary artery disease	0.00169	0.00172	CcSEcCtD
Mecamylamine—Shock—Timolol—coronary artery disease	0.00169	0.00172	CcSEcCtD
Mecamylamine—Asthenia—Enalapril—coronary artery disease	0.00169	0.00171	CcSEcCtD
Mecamylamine—Dizziness—Valsartan—coronary artery disease	0.00168	0.0017	CcSEcCtD
Mecamylamine—Anorexia—Ramipril—coronary artery disease	0.00168	0.0017	CcSEcCtD
Mecamylamine—Nausea—Ezetimibe—coronary artery disease	0.00167	0.0017	CcSEcCtD
Mecamylamine—Dizziness—Olmesartan—coronary artery disease	0.00167	0.00169	CcSEcCtD
Mecamylamine—Asthenia—Telmisartan—coronary artery disease	0.00166	0.00169	CcSEcCtD
Mecamylamine—Anorexia—Timolol—coronary artery disease	0.00164	0.00166	CcSEcCtD
Mecamylamine—Nausea—Eplerenone—coronary artery disease	0.00164	0.00166	CcSEcCtD
Mecamylamine—Dizziness—Niacin—coronary artery disease	0.00163	0.00166	CcSEcCtD
Mecamylamine—Asthenia—Captopril—coronary artery disease	0.00162	0.00164	CcSEcCtD
Mecamylamine—Vomiting—Valsartan—coronary artery disease	0.00161	0.00164	CcSEcCtD
Mecamylamine—Dizziness—Pravastatin—coronary artery disease	0.00161	0.00163	CcSEcCtD
Mecamylamine—Vomiting—Olmesartan—coronary artery disease	0.00161	0.00163	CcSEcCtD
Mecamylamine—Nausea—Simvastatin—coronary artery disease	0.0016	0.00162	CcSEcCtD
Mecamylamine—Paraesthesia—Ramipril—coronary artery disease	0.00158	0.0016	CcSEcCtD
Mecamylamine—Shock—Lisinopril—coronary artery disease	0.00157	0.00159	CcSEcCtD
Mecamylamine—Asthenia—Perindopril—coronary artery disease	0.00157	0.00159	CcSEcCtD
Mecamylamine—Vomiting—Niacin—coronary artery disease	0.00157	0.00159	CcSEcCtD
Mecamylamine—Dizziness—Trandolapril—coronary artery disease	0.00156	0.00158	CcSEcCtD
Mecamylamine—Dizziness—Enalapril—coronary artery disease	0.00155	0.00158	CcSEcCtD
Mecamylamine—Paraesthesia—Timolol—coronary artery disease	0.00155	0.00157	CcSEcCtD
Mecamylamine—Vomiting—Pravastatin—coronary artery disease	0.00155	0.00157	CcSEcCtD
Mecamylamine—Dizziness—Telmisartan—coronary artery disease	0.00153	0.00155	CcSEcCtD
Mecamylamine—Decreased appetite—Ramipril—coronary artery disease	0.00153	0.00155	CcSEcCtD
Mecamylamine—Asthenia—Furosemide—coronary artery disease	0.00153	0.00155	CcSEcCtD
Mecamylamine—Anorexia—Lisinopril—coronary artery disease	0.00152	0.00154	CcSEcCtD
Mecamylamine—Fatigue—Ramipril—coronary artery disease	0.00152	0.00154	CcSEcCtD
Mecamylamine—Nausea—Valsartan—coronary artery disease	0.00151	0.00153	CcSEcCtD
Mecamylamine—Constipation—Ramipril—coronary artery disease	0.00151	0.00153	CcSEcCtD
Mecamylamine—Nausea—Olmesartan—coronary artery disease	0.0015	0.00152	CcSEcCtD
Mecamylamine—Vomiting—Trandolapril—coronary artery disease	0.0015	0.00152	CcSEcCtD
Mecamylamine—Decreased appetite—Timolol—coronary artery disease	0.0015	0.00152	CcSEcCtD
Mecamylamine—Vomiting—Enalapril—coronary artery disease	0.00149	0.00152	CcSEcCtD
Mecamylamine—Dizziness—Captopril—coronary artery disease	0.00149	0.00151	CcSEcCtD
Mecamylamine—Fatigue—Timolol—coronary artery disease	0.00148	0.0015	CcSEcCtD
Mecamylamine—Vomiting—Telmisartan—coronary artery disease	0.00147	0.00149	CcSEcCtD
Mecamylamine—Asthenia—Losartan—coronary artery disease	0.00147	0.00149	CcSEcCtD
Mecamylamine—Nausea—Niacin—coronary artery disease	0.00147	0.00149	CcSEcCtD
Mecamylamine—Dizziness—Perindopril—coronary artery disease	0.00145	0.00147	CcSEcCtD
Mecamylamine—Nausea—Pravastatin—coronary artery disease	0.00144	0.00146	CcSEcCtD
Mecamylamine—Paraesthesia—Lisinopril—coronary artery disease	0.00143	0.00145	CcSEcCtD
Mecamylamine—Vomiting—Captopril—coronary artery disease	0.00143	0.00145	CcSEcCtD
Mecamylamine—Dizziness—Furosemide—coronary artery disease	0.00141	0.00143	CcSEcCtD
Mecamylamine—Nausea—Trandolapril—coronary artery disease	0.0014	0.00142	CcSEcCtD
Mecamylamine—Nausea—Enalapril—coronary artery disease	0.0014	0.00142	CcSEcCtD
Mecamylamine—Vomiting—Perindopril—coronary artery disease	0.00139	0.00141	CcSEcCtD
Mecamylamine—Decreased appetite—Lisinopril—coronary artery disease	0.00139	0.00141	CcSEcCtD
Mecamylamine—Nausea—Telmisartan—coronary artery disease	0.00138	0.0014	CcSEcCtD
Mecamylamine—Fatigue—Lisinopril—coronary artery disease	0.00138	0.0014	CcSEcCtD
Mecamylamine—Constipation—Lisinopril—coronary artery disease	0.00137	0.00138	CcSEcCtD
Mecamylamine—Dizziness—Losartan—coronary artery disease	0.00136	0.00138	CcSEcCtD
Mecamylamine—Vomiting—Furosemide—coronary artery disease	0.00135	0.00137	CcSEcCtD
Mecamylamine—Nausea—Captopril—coronary artery disease	0.00134	0.00136	CcSEcCtD
Mecamylamine—Vomiting—Losartan—coronary artery disease	0.00131	0.00132	CcSEcCtD
Mecamylamine—Nausea—Perindopril—coronary artery disease	0.0013	0.00132	CcSEcCtD
Mecamylamine—Nausea—Furosemide—coronary artery disease	0.00126	0.00128	CcSEcCtD
Mecamylamine—Asthenia—Ramipril—coronary artery disease	0.00126	0.00128	CcSEcCtD
Mecamylamine—Asthenia—Timolol—coronary artery disease	0.00123	0.00125	CcSEcCtD
Mecamylamine—Nausea—Losartan—coronary artery disease	0.00122	0.00124	CcSEcCtD
Mecamylamine—Dizziness—Ramipril—coronary artery disease	0.00116	0.00118	CcSEcCtD
Mecamylamine—Asthenia—Lisinopril—coronary artery disease	0.00115	0.00116	CcSEcCtD
Mecamylamine—Dizziness—Timolol—coronary artery disease	0.00114	0.00115	CcSEcCtD
Mecamylamine—Vomiting—Ramipril—coronary artery disease	0.00112	0.00113	CcSEcCtD
Mecamylamine—Vomiting—Timolol—coronary artery disease	0.00109	0.00111	CcSEcCtD
Mecamylamine—Dizziness—Lisinopril—coronary artery disease	0.00106	0.00107	CcSEcCtD
Mecamylamine—Nausea—Ramipril—coronary artery disease	0.00105	0.00106	CcSEcCtD
Mecamylamine—Nausea—Timolol—coronary artery disease	0.00102	0.00104	CcSEcCtD
Mecamylamine—Vomiting—Lisinopril—coronary artery disease	0.00102	0.00103	CcSEcCtD
Mecamylamine—Nausea—Lisinopril—coronary artery disease	0.000948	0.000962	CcSEcCtD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.000722	0.0527	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.000547	0.0399	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.000415	0.0303	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.000379	0.0277	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.000379	0.0277	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.000332	0.0242	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000314	0.0229	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000314	0.0229	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000287	0.0209	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000267	0.0195	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000256	0.0187	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00024	0.0175	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—KCNJ8—coronary artery disease	0.000238	0.0174	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000236	0.0172	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000233	0.017	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.00022	0.0161	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00022	0.016	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—KCNJ8—coronary artery disease	0.000218	0.0159	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000216	0.0157	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000214	0.0156	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000196	0.0143	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000196	0.0143	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—KCNJ8—coronary artery disease	0.000194	0.0142	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000192	0.014	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000185	0.0135	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—KCNJ2—coronary artery disease	0.000181	0.0132	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.00018	0.0132	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000169	0.0123	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—KCNJ2—coronary artery disease	0.000165	0.0121	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000165	0.012	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000158	0.0115	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000157	0.0114	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000152	0.0111	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000151	0.011	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—KCNJ2—coronary artery disease	0.000147	0.0108	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000147	0.0107	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000145	0.0106	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000144	0.0105	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000139	0.0101	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000139	0.0101	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—PLCB3—coronary artery disease	0.000138	0.0101	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000129	0.00945	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000129	0.0094	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000127	0.00927	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—PLCB3—coronary artery disease	0.000126	0.00923	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000124	0.00904	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000121	0.00883	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000119	0.00866	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—ALDH2—coronary artery disease	0.000116	0.00849	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000113	0.00827	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000113	0.00824	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—PLCB3—coronary artery disease	0.000113	0.00823	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000112	0.00819	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000109	0.00797	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000109	0.00792	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CAMK2D—coronary artery disease	0.000106	0.00777	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—ALDH2—coronary artery disease	0.000106	0.00777	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	9.94e-05	0.00725	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CAMK2D—coronary artery disease	9.74e-05	0.0071	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—PLCB1—coronary artery disease	9.69e-05	0.00707	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—ALDH2—coronary artery disease	9.5e-05	0.00693	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	9.46e-05	0.0069	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—PLCB1—coronary artery disease	9.1e-05	0.00664	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CAMK2D—coronary artery disease	8.69e-05	0.00634	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	8.65e-05	0.00631	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—PLCB1—coronary artery disease	8.32e-05	0.00607	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	7.93e-05	0.00579	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	7.91e-05	0.00577	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	7.74e-05	0.00565	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—PLCB1—coronary artery disease	7.43e-05	0.00542	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	7.06e-05	0.00515	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.5e-05	0.00475	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	6.14e-05	0.00448	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CREB1—coronary artery disease	5.95e-05	0.00434	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	5.89e-05	0.0043	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	5.87e-05	0.00429	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CREB1—coronary artery disease	5.31e-05	0.00387	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	4.99e-05	0.00364	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CREB1—coronary artery disease	4.98e-05	0.00364	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	4.89e-05	0.00357	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CREB1—coronary artery disease	4.56e-05	0.00333	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	4.48e-05	0.00326	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TNF—coronary artery disease	4.27e-05	0.00312	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CREB1—coronary artery disease	4.07e-05	0.00297	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	3.99e-05	0.00291	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.68e-05	0.00268	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL6—coronary artery disease	3.45e-05	0.00252	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.36e-05	0.00245	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3e-05	0.00219	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—MAPK1—coronary artery disease	2.82e-05	0.00206	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—MAPK1—coronary artery disease	2.58e-05	0.00188	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—MAPK1—coronary artery disease	2.3e-05	0.00168	CbGpPWpGaD
